Day: February 16, 2024

Japan first in the world to approve Dupixent® for chronic spontaneous urticaria (CSU)Approval based primarily on results from Phase 3 trial showing Dupixent significantly reduced itch compared to placebo CSU is the fifth approved indication for Dupixent in Japan and the sixth indication for Dupixent globallyParis and Tarrytown, N.Y. February 16, 2024. The Ministry of Health, Labor and Welfare (MHLW) in Japan has granted marketing and manufacturing authorization for Dupixent® (dupilumab) for the treatment of chronic spontaneous urticaria (CSU) in people aged 12 years and older whose disease is not adequately controlled with existing therapy. Japan is the first country to approve Dupixent for CSU, emphasizing the value of Dupixent as a novel treatment option to manage this disease in patients with unmet needs. CSU is a chronic inflammatory...

Approval based on results from Phase 3 trial showing Dupixent significantly reduced itch compared to placebo CSU is the fifth approved indication for Dupixent in Japan and the sixth indication for Dupixent globally TARRYTOWN, N.Y. and PARIS, Feb. 16, 2024 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the Ministry of Health, Labor and Welfare (MHLW) in Japan has granted marketing and manufacturing authorization for Dupixent® (dupilumab) for the treatment of chronic spontaneous urticaria (CSU) in people aged 12 years and older whose disease is not adequately controlled with existing therapy. Japan is the first country to approve Dupixent for CSU, emphasizing the value of Dupixent as a novel treatment option to manage this disease in patients with unmet needs. CSU is a chronic inflammatory...

VANCOUVER, British Columbia, Feb. 15, 2024 (GLOBE NEWSWIRE) — B2Gold Corp. (TSX: BTO, NYSE AMERICAN: BTG, NSX: B2G) (“B2Gold” or the “Company”) deeply regrets to report that three B2Gold employees have passed away as a result of injuries sustained in an off-site incident in Mali earlier today. B2Gold wishes to express its deepest condolences to the families of the deceased employees. Traveling under Malian gendarme escort, a bus transporting B2Gold employees from the Fekola Mine to Bamako was involved in an incident when it was attacked approximately 75 kilometers west of Bamako. Initial reports have identified this tragic event as the result of an attack on the employee transport convoy, which included Malian gendarmerie vehicles in front and in the rear of the transport convoy. Unfortunately, the incident resulted in the death...

Ad Hoc Announcement Pursuant to Article 53 of the SIX Exchange Regulation Listing Rules RECORD RESULTS FOR SALES, CASH FLOW, AND ADJUSTED EBIT Results 2023Record sales of CHF 11,238.6 million (+7.1%), sales increase in local currencies of +14.5% Operating profit (EBIT) adjusted for one-time M&A effects increased to CHF 1,680.6 million (+12.7%), resulting in an EBIT margin of 15.0% (previous year: 14.2%) Operating profit (EBIT) reported at CHF 1,549.1 million (previous year: CHF 1,579.7 million) Record operating free cash flow up to CHF 1,372.7 million (+58.7%) Proposal for dividend increase to CHF 3.30 per share (previous year: CHF 3.20) Successful MBCC integration with synergies in the first 8 months of CHF 41 million 108 new patents and 188 new inventions registered Reduction of CO2eq emissions per ton sold by -4.4% (scope 1...

VANCOUVER, British Columbia, Feb. 15, 2024 (GLOBE NEWSWIRE) — EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) announced today it will report its financial results for the first quarter ended December 31, 2023 on Thursday, February 22, 2024 after market close. The financial statements and MD&A will be available on SEDAR+ at www.sedarplus.ca and on the Company’s website in the late evening Vancouver time. The Company has scheduled a conference call to discuss the results for Q1 2024 and business outlook on Friday, February 23, 2024 at 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time). Brent Charleton, Chief Executive Officer and Dylan Murray, Chief Financial Officer will present EnWave’s results and host a question and answer period. Conference Call Details:Date: February 23, 2024Time: 7:00am...

VANCOUVER, British Columbia, Feb. 15, 2024 (GLOBE NEWSWIRE) — Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified, premium cannabis, is pleased to announce the appointment of Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”) and grants restricted share units (“RSUs”). Appointment of Chief Executive Officer The board of directors of the Company (the “Board”) is pleased to announce the appointment of Margaret Brodie as the Chief Executive Officer of the Company, effective immediately. Since January 1, 2023, Ms. Brodie has acted as the Interim CEO and CFO. This appointment comes after the Board completed a search and evaluation of both internal and external candidates to lead the Company. “We are delighted...

BURNABY, British Columbia, Feb. 15, 2024 (GLOBE NEWSWIRE) — INTERFOR CORPORATION (“Interfor” or the “Company”) (TSX: IFP) announced today that it will indefinitely curtail its sawmill operations in Philomath, Oregon. This curtailment is in response to persistent high log costs in the region and ongoing weak lumber market conditions. Sawmill production will be curtailed immediately followed by an orderly wind-down of operations, which is expected to be completed by the end of the first quarter of 2024. The Philomath sawmill produces a mix of kiln-dried and green Hemlock and Douglas-fir dimensional lumber and timbers and has an annual capacity of 220 million board feet. “This was a difficult decision to make, but is necessary in light of the evolving operating and market environment,” said Bruce Luxmoore, Executive Vice-President...